Dr. Paddy Barrett

OCTOBER 11, 2024

Obesity is one of the world’s biggest health crisis and only seems to be getting worse. For over 50 years, the rates of obesity have continued to rise worldwide 1. The most recent data on obesity has shown a decline for the first time in a very long time. Between 2020 and 2023, the rates of obesity dropped by about 2% 2.

Obesity 81

Obesity Cancer Dementia Coronary Artery Disease 81

American College of Cardiology

NOVEMBER 18, 2024

Popular anti-obesity drugs continue to show cardiovascular benefits beyond weight loss, according to new research published in JACC and simultaneously presented at AHA 2024.

Obesity 70

Obesity Research Article 70

Circulation

JANUARY 27, 2025

The 2025 AHA Statistical Update is the product of a full years worth of effort in 2024 by dedicated volunteer clinicians and scientists, committed government professionals, and AHA staff members.

Heart Disease 81

Heart Disease Peripheral Arterial Disease Strokes Stroke 81

HCPLive

MARCH 8, 2024

On March 08, 2024, the FDA approved semaglutide 2.4 mg (Wegovy) to reduce cardiovascular risk in adults with obesity or overweight and heart disease based on the SELECT trial.

Obesity 124

Obesity Heart Disease 124

American College of Cardiology

JUNE 24, 2024

Semaglutide reduces body weight to a greater extent in women with obesity-related heart failure with preserved ejection fraction (HFpEF) than in men, and improved Kansas City Cardiomyopathy Questionnaire Clinical Summary Score (KCCQ-CSS) to the same extent in both women and men, according to results from a prespecified secondary analysis of pooled (..)

Preserved Ejection Fraction 66

Preserved Ejection Fraction Obesity Heart Failure Cardiomyopathy 66

HCPLive

APRIL 22, 2024

Thorndike discussed highlights from her ACP 2024 talk titled ‘Annals Beyond the Guidelines: How Would You Treat this Patient with Obesity?’

Obesity 52

Obesity 52

CardiacWire

JANUARY 15, 2025

Bayers FINEARTS-HF study revealed that finerenone could be poised to become the next big heart failure treatment at ESC 2024, and a new series of JACC sub-studies just further strengthened its case.

Heart Failure 59

Heart Failure Obesity BMI 59

Cardiometabolic Health Congress

JUNE 27, 2024

Competence in selecting treatments for long-term obesity management rose from 43% pre-test to 95% post-test. Neha Agarwal, PhD, Clinical Director at Cardiometabolic Health Congress , Informa Connect, recently presented significant findings at the 84th American Diabetes Association (ADA) Scientific Sessions.

CME 59

CME Diabetes Obesity Education 59

Medical Xpress - Cardiology

OCTOBER 15, 2024

Obesity is a widespread public health challenge in the Middle East, maintaining prevalence in 54.2% Overweight and obese women have a higher risk of hypertension and cardiovascular risk factors than women with a standard BMI, according to an analysis of the ANCORS-YW STUDY presented at ACC Middle East 2024. of women and 31.4%

Obesity 52

Obesity Hypertension Public Health BMI 52

HCPLive

MARCH 1, 2024

The rheumatology month in review highlights cognitive dysfunction in patients with fibromyalgia, explores the impact of obesity on treatment response in rheumatoid arthritis, and evaluates work-related challenges faced by patients with psoriatic arthritis.

Obesity 64

Obesity 64

Cardiometabolic Health Congress

DECEMBER 5, 2024

The American Heart Association (AHA) Congress 2024 , held from November 1618, marked a pivotal moment in cardiovascular and metabolic health. SUMMIT Trial : Weekly subcutaneous tirzepatide showed significant reductions in CV death and HF-related events among patients with HFpEF and obesity. Read the published study. View the study.

CME 52

CME Obesity Innovation Cardiovascular Disease 52

Cardiometabolic Health Congress

JANUARY 15, 2025

This imbalance is partly due to limited healthcare access, fewer preventive resources, and challenges in addressing risk factors such as obesity and diabetes. For example, the global spread of obesity, particularly among youth, has set the stage for a future pandemic of non-communicable diseases.

Atherosclerosis 59

Atherosclerosis Plaque Myocardial Infarction Risk Factors 59

Circulation

JANUARY 24, 2024

The 2024 AHA Statistical Update is the product of a full year’s worth of effort in 2023 by dedicated volunteer clinicians and scientists, committed government professionals, and AHA staff members.

Heart Disease 81

Heart Disease Peripheral Arterial Disease Strokes Stroke 81

Dr. Paddy Barrett

AUGUST 9, 2024

The 14 Factors Include: Hearing Loss High LDL cholesterol Less Education Traumatic Brain Injury Depression Social Isolation Hypertension Obesity Smoking Excess Alcohol Diabetes Physical Inactivity Air Pollution Visual Loss Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission When You Intervene Matters.

Dementia 115

Dementia Blood Pressure Obesity Cholesterol 115

Cardiometabolic Health Congress

SEPTEMBER 13, 2024

The European Society of Cardiology (ESC) Congress 2024 (August 30 – September 2, 2024) has wrapped up, delivering groundbreaking insights into cardiovascular diseases and related conditions. Suggest using MRAs before beta-blockers in cases of resistant hypertension. Explore 2024 ESC Updated Guidelines here.

Hypertension 59

Hypertension Cardiovascular Disease Bicuspid/Mitral Arrhythmia 59

Cardiology Update

APRIL 9, 2024

The American College of Cardiology (ACC) held its 73 rd annual scientific session and expo April 6-8, 2024 in Atlanta, Georgia. STEP-HFpEF DM 5 ( NCT04916470 ) explored the effects of semaglutide in obesity-related HF with preserved ejection fraction (HFpEF) and type 2 diabetes. April 6, 2024. April 7, 2024. Atlanta, GA.

Angina 52

Angina Myocardial Infarction Aortic valve Coronary Artery Disease 52

DAIC

JUNE 18, 2024

A projected rise in heart disease and stroke – along with several key risk factors, including high blood pressure and obesity – is likely to triple related costs to $1.8 christine.book Tue, 06/18/2024 - 11:22 June 18, 2024 — At least 6 in 10 adults in an older, more diverse U.S. Obesity rates are expected to climb from 43.1%

Heart Disease 105

Heart Disease Blood Pressure Strokes Stroke 105

Circulation

NOVEMBER 11, 2024

Circulation, Volume 150, Issue Suppl_1 , Page A4125500-A4125500, November 12, 2024. Background:Impaired left atrial (LA) function is observed in obese patients, however, there is little information on when LA dysfunction begins to appear. kg/m2; obese (n=15), ≧20 kg/m2.

Obesity 40

Obesity BMI Blood Pressure Circulation 40

DAIC

MARCH 26, 2024

milla1cf Tue, 03/26/2024 - 13:00 March 26, 2024 — Esperion announced the acceptance of three CLEAR ( C holesterol L owering via B e mpedoic acid, an A CL-Inhibiting R egimen ) Outcomes subgroup analyses as poster presentations at th e 2024 American College of Cardiology’s Annual Scientific Session ( ACC.24

Outcomes 105

Outcomes Obesity Cardiovascular Disease Atherosclerosis 105

Circulation

NOVEMBER 11, 2024

Circulation, Volume 150, Issue Suppl_1 , Page A4143390-A4143390, November 12, 2024. Clinical and hemodynamic implications of having obesity in group 1 PH remain unknown.Hypothesis. There was no difference in survival among patients with and without obesity (HR 1.15; 95% CI 0.95-1.38; Obese patients had higher RAP (12.8 ± 6.8

Obesity 40

Obesity Pulmonary Hypertension Diabetes 40

HCPLive

APRIL 23, 2024

Another segment of her ACP 2024 interview featured a discussion on weight loss drugs, healthy living, and discussions with patients.

Obesity 59

Obesity 59

DAIC

JANUARY 29, 2024

Survival outcomes were equivalent between MAG and SAG for patients aged 80 years or older, and those with severe heart failure , renal failure, peripheral vascular disease, or obesity. The only patients where single arterial grafting resulted in better survival were severely obese,” said Dr. Sabik.

Coronary Artery Bypass Graft 105

Coronary Artery Bypass Graft Research BMI Obesity 105

Circulation

NOVEMBER 11, 2024

Circulation, Volume 150, Issue Suppl_1 , Page A4144999-A4144999, November 12, 2024. Obesity is associated with increased cardiovascular risk and adverse cardiac changes such as left ventricular hypertrophy (LVH) and in TOF higher body mass index (BMI) contributed to increase risk. mL/m2, p=0.04; RVEDVi 157.4±21.5 vs RVEDV 297.6±56.6

Obesity 40

Obesity BMI Pulmonary Circulation 40

The British Journal of Cardiology

AUGUST 6, 2024

Obesity is a global pandemic and is a recognised risk factor for cardiovascular diseases. Therefore, we conducted an observational study with a cohort of 196 participants, comparing various echocardiographic parameters in normal weight individuals and those who were overweight or obese but had no other risk factors.

Obesity 40

Obesity Risk Factors Cardiovascular Disease Cardiac Function 40

The British Journal of Cardiology

OCTOBER 8, 2024

Sodium-glucose cotransporter type 2 (SGLT2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists are established glucose-lowering and weight-lowering agents used in the management of type 2 diabetes mellitus and obesity.

Obesity 40

Obesity Diabetes Kidney Disease Heart Failure 40

Medical Xpress - Cardiology

NOVEMBER 18, 2024

Popular anti-obesity drugs continue to show cardiovascular benefits beyond weight loss, according to several new papers published in JACC that are being simultaneously presented at the American Heart Association's 2024 Scientific Sessions.

Obesity 40

Obesity Biomarkers Heart Failure Outcomes 40

Circulation

NOVEMBER 11, 2024

Circulation, Volume 150, Issue Suppl_1 , Page A4141434-A4141434, November 12, 2024. A growing body of clinical trial data shows GLP-1 receptor agonist medications (GLP-1s) are not only effective in treating obesity but also demonstrate significant impact on the reduction of cardiovascular risk. inches (n=3,682).

Obesity 40

Obesity Risk Factors Circulation Outcomes 40

The American Journal of Cardiology

JULY 24, 2024

Publication date: Available online 23 July 2024 Source: The American Journal of Cardiology Author(s): Dr. Philip D.

Obesity 40

Obesity 40

DAIC

JUNE 28, 2024

Getty Images milla1cf Fri, 06/28/2024 - 08:10 June 27, 2024 — Cardiovascular disease is the leading cause of death for women, and gaps in care and access persist between women and men. The new fund expects to start deploying capital in late 2024. Addressing those gaps could lead to an increase of at least 1.6

Cardiovascular Disease 105

Cardiovascular Disease Obesity Research Heart Disease 105

Circulation

NOVEMBER 11, 2024

Circulation, Volume 150, Issue Suppl_1 , Page A4138745-A4138745, November 12, 2024. Insulin signaling was assessed 15 minutes after stimulation with 17 nM insulin.Results:Esaxerenone improved insulin sensitivity (P<0.05) without altering metabolic parameters in HFD-induced obese and db/db mice.

Obesity 40

Obesity Blood Pressure Diet Diabetes 40

Circulation

NOVEMBER 11, 2024

Circulation, Volume 150, Issue Suppl_1 , Page A4112652-A4112652, November 12, 2024. Background:Metabolic syndrome and obesity are known to increase the incidence of lung cancer. 0.98, p = 0.040; MUO: adjusted HR 0.76, 95% CI 0.60-0.96, 0.96, p = 0.022).Conclusions:After

Obesity 40

Obesity Cancer Outcomes Circulation 40

Stroke Journal

FEBRUARY 1, 2024

Stroke, Volume 55, Issue Suppl_1 , Page ATP277-ATP277, February 1, 2024. Hypertension and obesity were defined using AHA and CDC guidelines. had obesity. Compared with nuclear, multigenerational households showed higher hypertension and obesity odds yet did not reach statistical significance. had hypertension, 58.2%

Obesity 40

Obesity Risk Factors Hypertension Strokes 40

GEMMS

MAY 22, 2024

Much of heart disease is linked to conditions like diabetes, obesity, or chronic kidney disease, and specific mutations in nucleic acids help identify them. The post Top 10 Cardiac Diagnosis Trends in 2024 appeared first on GEMMS. Genetic testing and DNA sequencing improve the accuracy of predicting heart disease risk.

Heart Disease 52

Heart Disease Blood Pressure Technology Innovation 52

DAIC

MARCH 26, 2025

2 Most are balancing multiple comorbidities, such as obesity, diabetes, hypertension and chronic kidney disease (CKD). In fact, a 2024 report on heart failure trends and outcomes published in the Journal of Cardiac Failure showed that in patients with heart failure with preserved ejection fraction, 5-year mortality was 75.7%.

Heart Failure 52

Heart Failure Preserved Ejection Fraction Kidney Disease ACE Inhibitor 52

Cardiometabolic Health Congress

MARCH 1, 2024

The not-so-sudden rise of weight loss ”wonder” drugs for T2D and obesity This World Obesity Day, March 4, 2024, weight loss drugs dominate discussions and raise new questions for clinicians. In the last decade, several more medications in this class have been approved for use in T2D and obesity.

Obesity 59

Obesity Diabetes 59

Stroke Journal

FEBRUARY 1, 2024

Stroke, Volume 55, Issue Suppl_1 , Page A13-A13, February 1, 2024. Elderly obese stroke survivors (> 65 years) having a recurrent acute ischemic stroke (AIS), with or without prior bariatric surgery (PBS), were identified using ICD-10 codes. Both groups (PBS vs. no PBS) were predominantly female (59.7% vs. 90.7%).

Obesity 40

Obesity Inpatient Strokes Stroke 40

The American Journal of Cardiology

OCTOBER 6, 2024

Publication date: Available online 5 October 2024 Source: The American Journal of Cardiology Author(s): Ishaque Hameed, Khushboo Nusrat, Adeena Jamil, Kaneez Fatima, Abdul Mannan Khan Minhas, Stephen J. Greene, Andrew J Sauer, Javed Butler, Muhammad Shahzeb Khan

Cardiovascular Disease 52

Cardiovascular Disease Obesity 52